Announcing Your 2015 TIDES Keynote Lineup

IBC's 17th Annual TIDES meeting is coming to San Diego, CA on May 3-6, 2015.This is the leading forum for CMC, clinical and discovery scientists in the oligonucleotide and peptide industry to share best practices and new technologies to help you:

• • Accelerate your promising therapeutic to market
• • Ensure accurate CMC submissions
• • Comply with emerging regulatory expectations
• • Apply best practices from leading preclinical/clinical projects
• • Improve process development timelines

Download the preliminary agenda.

This year, we move coasts and provide you visionary keynotes sharing key success factors for drug development and manufacturing highlighting these areas:

• >Antisense Technology: Stanley T. Crooke, Ph.D., Chief Executive Officer, Isis Pharmaceuticals, Inc.
• >RNAi Therapeutics: John Maraganore, Ph.D., Chief Executive Officer, Alnylam Pharmaceuticals
• >Peptide Therapeutics: Torsten Hoffmann, Ph.D., Executive VP and CSO, Zealand Pharma A/S
• >Oral Peptide: Kunwar Shailubhai, Ph.D., Co-Founder & CSO, Synergy Pharmaceuticals, Inc.

And don't forget - as a reader of this blog, when you register to join us and mention code XB15180BLOG, you can save 20% off the standard rate!

Share this article with your social network, just click below to share now!

Share |